STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ROSUVASTATIN (CALCIUM) IN PHARMACEUTICAL DOSAGE FORM

Authors

  • Zahi Mohammad Turabi Quality Control Department, Sama Pharmaceuticals Manufacturing Co., Nablus, Palestine
  • O’hood Atef Khatatbeh Quality Control Department, Sama Pharmaceuticals Manufacturing Co., Nablus, Palestine

Abstract

A stability indicating, accurate, specific, linear and sensitive reverse phase-HPLC method has been developed and validated for the determination of Rosuvastatin as calcium, (ROS) in pharmaceutical dosage form. The chromatographic separation was performed using end capped (Luna) C18 Column (250 mm × 4.6 mm, 5μm particle size). Mobile phase A was prepared by mixing 3.0g/l Ammonium dihydrogen phosphate in distilled water: Methanol: Acetonitrile: Tetrahydrofuran in the ratios (400:20:100:5v/v). To 1000 ml of the resulting solution 1 ml of triethylamine was added then the pH was adjusted to 6.3 with 5% v/v orthophosphoric acid. Mobile phase B was prepared by mixing Acetonitrile: Methanol: Tetrahydrofuran in the ratios (500:50:5v/v). Other chromatographic conditions such as flow rate set at 2.0 ml/min and 30°C column temperature with the detection wavelength at 243nm. The retention times of Rosuvastatin was found to be about 16 min. The linearity was performed in the concentration range of 40.0-60.0μg/ml with a squared correlation coefficient of 0.99998. The percentage purity of ROS was found to be >99.8%. The percentage recovery was determined for ROS and was found to be 100.067%. The developed analytical method has been validated for specificity, linearity, precision, accuracy, ruggedness and robustness which were within the acceptance limit according to ICH guidelines. All the degradation products obtained by stress conditions were found to be well separated from the principal peak, which means that the ROS peaks were highly pure in all chromatograms obtained. The developed method was successfully employed for routine quality control and stability analysis of ROS in pharmaceutical dosage forms.

Keywords:

Rosuvastatin Calcium, Stability-Indicating, RP-HPLC, Validation

DOI

https://doi.org/10.25004/IJPSDR.2014.060214

References

1. Mostafa NM, Badawey AM, Lamie NT, Abd El-Aleem AB. Stability-indicating methods for the determination of rosuvastatin calcium in the presence of its oxidative degradation products. Int J Pharm Biomed Sci. 2012; 3: 193-202.
2. Kaila HO, Ambasana MA, Thakkar RS, Saravaia HT, Shan AK. A new improved RP-HPLC Method for assay of rosuvastatin calcium in tablets. Indian J of Pharmaceutical Sciences 2010; 72: 592-598.
3. Thriveni J, Rambabu R, Rao JV, Vidyadhara S. Development and validation of RP-HPLC method for simultaneous estimation of rosuvastatin calcium and fenofibrate in bulk and pharmaceutical dosage forms. International J of Research in Pharmacyand chemistry 2013; 3: 208-212.
4. Moinuddin M, Rahman SA, Yadav BR, Battu R. Development and validation of a reverse phase HPLC method for simultaneous estimation of rosuvastatin calcium and fenofibrate in tablet dosage form. International Journal of Pharmacy and Pharmaceutical Sciences 2012; 4: 150-154.
5. Tajan D, Raurale AM, Bharande PD, Mali AN, Gadkari AV, Bhosale VR. Development and validation of a RP-HPLC-PDA method for the simultaneous determination of rosuvastatin calcium and amlodipine besilate in pharmaceutical dosage form. J of Chemical and Pharmaceutical Research 2012; 4: 2789-2794.
6. Pandia CB, Channabasavaraj KP, Chudasama JD, Mani TT. Development and validation of RP-HPLC method for determination of rosuvastatin calcium in bulk and pharmaceutical dosage form. J of Pharmaceutical Sciences Review and Research 2010; 5: 82-86.
7. Godavariya Vijay D, Prajapati Pintu B, Morolia Bhavin P, Shah Sailesh A. Development and validation of RP-HPLC method for the simultaneous estimation of rosuvastatin calcium and aspirin in marketed formulation. International Research J of Pharmacy 2012; 3: 173-175.
8. Donthula S, Kumar MK, Teja GS, Kumar YM, Krishana JY, Ramesh D. A new validated RP-HPLC method for determination of rosuvastatin calcium in bulk and pharmaceutical dosage form. Der Pharmacia Lettre 2011; 3:350-356.
9. Trivedi HK, Patel MC. Development and validation of a stability-indicating RP-UPLC method for determination of rosuvastatin and related substancesin pharmaceutical dosage form. Scientia Pharmaceutica. 2012; 80:393-406.
10. Thukabai S, V. Rao VUM, Shaik MR. Development and validation of RP-HPLC method for simultaneous estimation of rosuvastatin and fenofibrate in bulk and tablet dosage form. International J of Pharmacy 2013; 3: 607-612.
11. Rao AL, Suneetha D. Development and validation of RP-HPLC method for the estimation of rosovastatin in bulk and pharmaceutical dosage form. Int. J. Cem. Sci. 2010; 8: 2010.
12. Shah Y, Iqbal Z, Ahmad L, Khan A, Khan Ml, Nazir S, Nazir F. Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detiction: method development , validation and optimization of various experimental parameters. J Chromatogr B Analyt Technol Biomed Life Sci. 2011; 879: 557-563.
13. Joshi H, Kumar S, Yadav YC, Seth AK. New analytical method development and validation of rosuvastatin and Ezetimibe in tablet dosage form. International J of Drug Discovery and Medical Research 2012; 1:22-29.
14. Varma DPSRChNP, Rao AL, Dinda SC. Development and validation of stability indicating RP-HPLC method for simultaneous estimation of rosuvastatin and ezetimibe in combined tablet dosage form. Rasayan J Chem. 2012; 5: 269-279.
15. Gupta A, Mishra P, Shah K. Simple UV. Spectrophotometric determination of rosuvastatin calcium in pure form and in pharmaceutical formulations. E. J Chem. 2009; 6: 89-92.
16. Krishna MV, Sankar DG. Extractive spectrophotometric methods for the determination of rosuvastatin calcium in pure form and in pharmaceutical formulations by using safranin O and methylen blue. E. J Chem. 2007; 4: 46-49.
17. Singh RM, Ansari TA, Jamil S, Kumar Y. Spectrophotometric estimation of rosuvastatin calcium in tablet formulation. India Drugs 2005; 42: 244-245.
18. Sane RT, Kamat SS, Menon SN, Inamdar SR. Determination of rosuvastatin calcium in its bulk drug and pharmaceutical preparations by high-performance thin-layer chromatography. J Planer. Chromatogr. Mod. TLC. 2005; 18: 194-198
19. Chaudhari B, Patel N, Shah P. Determination of simvastatin, pravastatin sodium and rosuvastatin calcium in tablet dosage forms by HPTLC. Indian J Pharm. Sci. 2007; 69: 130-132.
20. Code Q2A-Text on Validation of Analytical Procedure Step-3 Consensus Guideline, 1994, ICH Harmonized Tripartite Guideline.
21. Code Q2B- Validation of Analytical Procedure Methodology Step- 4 Consensus Guideline, 1994, ICH Harmonized Tripartite Guideline.

Published

01-04-2014
Statistics
Abstract Display: 623
PDF Downloads: 380
Dimension Badge

How to Cite

“STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ROSUVASTATIN (CALCIUM) IN PHARMACEUTICAL DOSAGE FORM”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 6, no. 2, Apr. 2014, pp. 154-9, https://doi.org/10.25004/IJPSDR.2014.060214.

Issue

Section

Research Article

How to Cite

“STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ROSUVASTATIN (CALCIUM) IN PHARMACEUTICAL DOSAGE FORM”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 6, no. 2, Apr. 2014, pp. 154-9, https://doi.org/10.25004/IJPSDR.2014.060214.

Similar Articles

1-10 of 368

You may also start an advanced similarity search for this article.